Oncogenes are often activated in cancer cells, leading to uncontrolled cell growth and division.
癌基因通常在癌细胞中被激活,导致失控的细胞增殖和分裂。
The discovery of specific anti-oncogenes has opened new avenues for targeted cancer therapy.
特定抗癌基因的发现为靶向癌症疗法开辟了新的途径。
Oncogenes can be mutated or overexpressed, contributing to the development of various malignancies.
癌基因可能发生突变或过度表达,从而促进各种恶性肿瘤的发展。
Scientists are working on developing drugs that inhibit oncogenes to treat aggressive forms of cancer.
科学家们正在研发能够抑制癌基因的药物来治疗恶性程度高的癌症。
Epigenetic modifications can silence oncogenes, potentially reversing the effects of cancer-causing mutations.
基因表观修饰可以关闭癌基因,可能逆转致癌突变的影响。
Some researchers propose using gene therapy to replace mutated oncogenes with their normal, non-cancerous counterparts.
一些研究者提出使用基因疗法将突变的癌基因替换为正常、非癌性的等位基因。
Oncogenes play a dual role in cell signaling, both promoting growth and preventing apoptosis in healthy cells.
癌基因在细胞信号传导中具有双重作用,既促进生长又防止正常细胞的凋亡。
Understanding the complex interactions between oncogenes and tumor suppressor genes is crucial for cancer treatment strategies.
理解癌基因与抑癌基因之间的复杂相互作用对于癌症治疗策略至关重要。
The development of immunotherapies that target oncogenes has shown promise in treating certain types of advanced cancers.
针对癌基因的免疫疗法在治疗某些类型的晚期癌症方面显示出前景。
Oncogene-induced senescence is a mechanism by which cells respond to excessive activation of oncogenes, halting their proliferation and preventing cancer progression.
癌基因诱导的衰老是细胞对过度激活癌基因的反应机制,它阻止细胞增殖并防止癌症进展。
未经许可,严禁转发。QQ交流群:688169419